Keywords: Boehringer Ingelheim, Pradaxa, Prescribing information, Anticoagulant, Heart valves, USA, FDA

Boehringer Ingelheim updates safety info for Pradaxa related to heart valve

Article | 21 December 2012

Print This

The US subsidiary of German independent drug major Boehringer Ingelheim says that the US prescribing information for its blood thinner ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in